We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00002948
Recruitment Status : Terminated
First Posted : January 27, 2003
Last Update Posted : July 2, 2014
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Yale University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : January 2004
  Study Completion Date : January 2004